Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. - Wikidata - awgldk - TriplyDB

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

http://www.wikidata.org/entity/Q42114097

about

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring.Polyomavirus BK and prostate cancer: a complex interaction of potential clinical relevance.Merkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies.Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma.T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.Design and optimisation of bioactive cyclic peptides: generation of a down-regulator of TNF secretion.Merkel cell polyomavirus and Merkel cell carcinoma.Two Types of Interleukin 17A-Producing γδ T Cells in Protection Against Pulmonary Infection With Klebsiella pneumoniae.Merkel Cell Carcinoma Concomitant with Invasive Bowen's Disease: Immunohistochemical Investigation of Tumor-Infiltrating Leukocytes Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study.Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells.Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers Metastatic Merkel cell carcinoma response to nivolumab.Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.Avelumab and other recent advances in Merkel cell carcinoma.Discovery of skin lymphocytes was a game changer in experimental dermatology.Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

P2860

Q27853379-485C7F3C-5064-49EE-A64B-A00B6C7A4883 Q33720183-D7D14F48-6175-4DFE-BE07-3F5CDA1C678C Q33938500-5A7D05FA-E46B-4AF9-8843-7699F05CD7EE Q36605917-2F541336-7377-4B2F-938D-D9AA2021A852 Q37290632-46E11FC5-F1EE-4C9D-A1BA-F4714DA58CF4 Q38574112-0829FEA3-40D6-41AB-A03F-54A536386400 Q38644262-379E439E-B7AD-43AF-8EE0-EBBCB68CE16C Q38714104-B5F6DE03-B1A3-4E74-93B9-4CFB1AF20BC4 Q38871209-15BAEEF1-7503-4D36-8EA5-ED56A2035937 Q38887303-250370E9-409C-4A1C-8C39-AD9A3BF05033 Q38926245-6C8FA113-6CAC-4C51-A6C9-77DDAFD00667 Q40046580-8E77C85F-1459-4413-971E-DA13BC94DC86 Q40532984-24972392-D698-47F0-AA25-7F1C63FCB1F2 Q41774280-C763F6BA-DA44-464B-9607-E5FAD56695A4 Q41851924-E86A8BEE-84FB-4E5C-A9DB-39C2F1CAA82B Q42160453-4B87424B-2C27-449D-8CF9-22878ABF17AF Q42278531-B4403D4B-B56F-4998-9E2D-90A963CDE745 Q42368667-E75CA7FF-922E-4EF1-BC80-F017972B10AB Q47584286-7155032C-CA44-4472-95A1-5A2C52B07DE7 Q47915808-514E3909-8F81-4FDF-9257-9D41D9AE96D1 Q48248474-21691D03-8477-44A8-86FC-54E7388DF6BD Q57057523-ABB2DBB2-D655-4183-A14B-2AF347FE7951

P2860

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

http://www.wikidata.org/entity/Q42114097

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@en

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@nl

type

label

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@en

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@nl

prefLabel

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@en

Tumor-specific T cells in huma ...... in reducing T-cell responses.

@nl

P1433

Q42114097-1903BDE5-88D5-494A-AD75-F1BD2081EB3C

P1476

Q42114097-D75DAA3A-DB87-4279-8246-1B2077316B4E

P2093

Q42114097-38E6EF07-9B8B-4A6A-8957-370E4C6EA185

Q42114097-4415377F-AC87-4D74-909B-54C63154D136

Q42114097-533E0050-7C7E-4818-9978-FCB158D1D2A6

Q42114097-745E7908-1382-4751-A6C1-61D47069566D

Q42114097-825859D5-B2DE-41D2-A367-895291B5940C

Q42114097-8B25E36E-F3D1-4A78-B13C-87184185160E

Q42114097-A0FB5BEB-F1FA-4662-9288-D70506F451C3

Q42114097-BBC746FD-BE5E-411A-91B1-DFACF92A1D2D

Q42114097-CE594B2F-4963-47AC-9634-829148571C2D

Q42114097-D57AB3F2-E3B1-4B68-8215-A5F67C274839

P2860

Q42114097-08F13DF5-6084-470F-94BE-F8AFB98FE29A

Q42114097-0B67B22E-C4AA-47EE-961D-22398604465D

Q42114097-0D5BBD03-4941-405B-890C-382917A9A5D0

Q42114097-15FD0E7C-78B2-4F8F-A290-2C93EC2A2E89

Q42114097-196B0536-5D69-41A6-A447-50F52D0AB584

Q42114097-1DF8287F-D891-4E32-BE3C-E4A84D8D1CC1

Q42114097-22BE9BAD-CD05-4B08-A9ED-DEED5175798F

Q42114097-244D7408-2C1D-4C79-9C57-2549FEEDD63A

Q42114097-2933CC4C-983C-4B34-ADDD-92554D9AD6AD

Q42114097-34A4FEC8-6B11-445D-B3A1-FDA18D9EB3BD

P2888

Q42114097-C81512E3-05BB-4C28-A0B8-54837CDC3DFF

P304

Q42114097-C83C83B2-CFBB-4121-BD48-940F35ED35E1

P31

Q42114097-92F10F93-1FF0-4DBE-B76D-BBAB6CBE2CED

P356

Q42114097-03DD118A-9732-4EFC-BD49-B54C38D35F95

P407

Q42114097-2EC27C9F-C32B-4BF5-AEA1-6D2225BF6D5E

P433

Q42114097-27DD561C-FF36-493A-B593-944E3ADA0B7A

P478

Q42114097-EFD20D3D-BB15-413E-ADCB-E3B802B5AA95

P50

Q42114097-A5EFDF91-DA01-4E2C-933D-9179B06BF99F

Q42114097-C4348903-CB87-4D1F-8414-EB9D8D3F8070

P577

Q42114097-646A5C0C-C80D-4E8E-82A0-1FCB20B1743E

P5875

Q42114097-8A4F70D6-F528-4522-B55D-BEB37312B1D5

P698

Q42114097-A4BFF63A-EC6A-4786-8322-06C104383169

P932

Q42114097-48075DEE-AF67-4657-A7DD-0619850D1AA8

P356

P1433

Journal of Investigative Dermatology

P1476

Tumor-specific T cells in huma ...... n in reducing T-cell responses

@en

P2093

Adam Calarese

http://www.w3.org/2001/XMLSchema#string

Ahmed E Gehad

http://www.w3.org/2001/XMLSchema#string

Andrew A Dorosario

http://www.w3.org/2001/XMLSchema#string

Carl F Schanbacher

http://www.w3.org/2001/XMLSchema#string

Chrysalyne D Schmults

http://www.w3.org/2001/XMLSchema#string

Jessica E Teague

http://www.w3.org/2001/XMLSchema#string

Jingwei Cheng

http://www.w3.org/2001/XMLSchema#string

Linda C Wang

http://www.w3.org/2001/XMLSchema#string

Manisha Thakuria

http://www.w3.org/2001/XMLSchema#string

Mitra Dowlatshahi

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus

Clonal integration of a polyomavirus in human Merkel cell carcinoma

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

Regulatory T cells: key controllers of immunologic self-tolerance.

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.

P2888

P304

1879-1889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2013.75

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235658329

http://www.w3.org/2001/XMLSchema#string

P698

23419694

http://www.w3.org/2001/XMLSchema#string

P932

3691077

http://www.w3.org/2001/XMLSchema#string